BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, March 25, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 3, 2005
View Archived Issues
Completion of EVOLUTION-On safety trial of Angiomax
Read More
Novel vanilloid receptor-1 antagonists described for the treatment of pain
Read More
Telcyta ASSIST-1 trial completes enrollment, new ASSIST-3 trial under way
Read More
Ligand and TAP extend research collaboration
Read More
APC-8024 shows antitumor activity in patients with advanced breast cancer
Read More
Good efficacy and safety profile reported for Sch-66336 plus paclitaxel in metastatic breast cancer
Read More
Preclinical evidence for the antitumor efficacy of panitumumab in breast cancer
Read More
Riluzole shows promise in the management of depression and anxiety disorders
Read More
Update on the efficacy of mifepristone in psychotic major depression
Read More
CytoGenix takes stock of 2004
Read More
Phase II study investigates aerosolized amikacin for VAP
Read More
Fornix reviews R&D progress
Read More
Japanese phase IIb results for Proglia in acute cerebral infarction
Read More
Swedish approval for Tostrex
Read More
Newron claims glycoside derivatives and their use in Parkinson's, Alzheimer's, etc.
Read More
Antibacterial monoclonal antibodies described in patent literature
Read More
Five Aventis patents disclose novel antithrombotic agents
Read More
Sodium channel blockers for treatment of pain in early development at Merck
Read More
Standard and novel mGluR5 antagonists in the treatment of cocaine addiction
Read More
Novel small-molecule Bcl-2 inhibitor induces apoptosis in breast cancer cells
Read More
Discovery of a glucagon receptor antagonist for the treatment of diabetes
Read More
Phytomedicine EPs-7630 targets bacterial adhesion
Read More
Lyrica approved for diabetic peripheral neuropathy, postherpetic neuralgia
Read More
